The Future of Health Physics: Trends, Challenges, and Innovation
Abstract
This paper offers a comprehensive exploration of the future trajectory of health physics, examining influential factors in external and internal dimensions. External factors include an in-depth analysis of low-dose (10-100 mSv) measurement challenges and priorities, highlighting the transformative potential of biomarkers in solving radiation susceptibility following low-dose exposures. Cutting-edge technologies are at the forefront, with insights into emerging radiation detection tools like plastic scintillators with triple discrimination capabilities and sensors based on plastic scintillation microspheres (PSm) for estimating α and β emitting radionuclides in environmental samples. Remote detection systems using drones, robot dogs, and quantum sensors boasting heightened sensitivity and precision also are discussed. Integrating artificial intelligence (AI) and data analytics emerges as a pivotal element, promising to redefine health physics by minimizing radiation exposure risks. The exploration includes innovative materials for radiation shielding, advancements in virtual reality applications, preparation for radiological protection during armed conflicts, and the ever-evolving landscape of decommissioning health physics. Examining health effects from non-ionizing radiation and analyzing broader contextual factors such as regulatory shifts, geopolitics, and socioeconomic influences adds depth to understanding the external forces leading to the future of health physics.…
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.